1-4 of 4
Kathleen E McGinness, PhD
Close
Sort by
Journal Articles

Investigation Into the Mechanism of Action and Binding Site of BAX 499, An Aptamer Against Tissue Factor Pathway Inhibitor

Emily K. Waters, PhD, Ryan M. Genga, Heather A. Thomson, Robert G. Schaub, PhD, Jeffrey C. Kurz, PhD, Kathleen E. McGinness, PhD
Journal: Blood
Blood (2011) 118 (21): 1214.
https://doi.org/10.1182/blood.V118.21.1214.1214
Published: 2011
Journal Articles

The Generation of An Aptamer Inhibitor of Murine Von Willebrand Factor (VWF) Mediated Platelet Aggregation

Melissa Woelfel, Simon De Meyer, PhD, Patricia Wagner, Kathleen E McGinness, PhD, Denisa D. Wagner, PhD, Robert Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 4312.
https://doi.org/10.1182/blood.V116.21.4312.4312
Published: 2010
Journal Articles

TFPI Antagonist Aptamer ARC19499 Is a Procoagulant In Vitro and In Vivo.

Kathleen E. McGinness, PhD, Emily K. Waters, PhD, Ryan M. Genga, Karen A. Olson, PhD, Jennifer A. Nelson, PhD, Jeffrey C. Kurz, PhD, Robert G. Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 1134.
https://doi.org/10.1182/blood.V116.21.1134.1134
Published: 2010
Journal Articles

An Aptamer Antagonist of Tissue Factor Pathway Inhibitor Improves Coagulation in Hemophilia A and FVIII Antibody-Treated Plasma.

Emily K. Waters, PhD, Jeffrey C. Kurz, PhD, Ryan Genga, Jennifer A Nelson, PhD, Kathleen E. McGinness, PhD, Robert G. Schaub, PhD
Journal: Blood
Blood (2009) 114 (22): 544.
https://doi.org/10.1182/blood.V114.22.544.544
Published: 2009